Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Bone
Reexamination Certificate
2002-05-10
2004-09-21
Jackson, Suzette J. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Bone
C623S908000, C427S099300
Reexamination Certificate
active
06793677
ABSTRACT:
FIELD OF THE INVENTION
This invention relates generally to the treatment of diseased or traumatized intervertebral discs, and more particularly, to transplantation of the nucleus pulposis in conjunction with such treatment.
BACKGROUND OF THE INVENTION
Intervertebral discs provide mobility and a cushion between the vertebrae. At the center of each disc is the nucleus pulposus which, in the adult human, is composed of cells and an insoluble extracellular matrix which is produced by the nucleus itself. The extracellular matrix is composed of collagen, proteoglycans, water, and noncollagenous proteins. The nucleus pulposus is surrounded by the annulus fibrosis, which is composed of cells (fibrocyte-like and chondrocyte-like), collagen fibers, and non-fibrillar extracellular matrix. The components of the annulus are arranged in 15-25 lamellae around the nucleus pulposus.
The cells of the nucleus pulposus have chondrocyte-like features. In an adult human, the cells of the nucleus pulposis obtain nutrients and eliminate waste by diffusion through blood vessels in the endplates of the vertebrae adjacent to the disc. Blood vessels do not course into the nucleus pulposis. The relative vascular isolation of the nucleus pulposis imparts isolation of nucleus pulposis cells from the body's immune system.
To date, the treatment of degenerative disc disease has relied for the most part on eliminating the defective disc or disc function. This may be accomplished by fusing the vertebra on either side of the disc. In terms of replacement, most prior-art techniques use synthetic materials to replace the entire disc or a portion thereof. My pending U.S. patent application Ser. No. 09/415,382 discloses disc replacement methods and apparatus using synthetic materials.
Unfortunately, disc replacement using synthetic materials does not restore normal disc shape, physiology, or mechanical properties. Synthetic disc replacements tend to wear out, resulting in premature failure. The problems associated with the wear of prosthetic hip and knees are well known to those skilled in orthopedic surgery. The future of treating degenerative disc disease therefore lies in treatments which preserve disc function. If disc function could be restored with biologic replacement or augmentation, the risk of premature wearout would be minimized, if not eliminated.
My U.S. patent application Ser. No. 09/639,309, filed Aug. 14, 2000, is directed to a method of treating a diseased or traumatized intervertebral disc through the transplantation of nucleus pulposis cells. Broadly according to the method, live nucleus pulposus cells are harvested from a human or animal donor and introduced into the disc being treated. The harvested nucleus pulposus cells are preferably kept viable until placed into the disc being treated.
A preferred embodiment includes morselizing the harvested nucleus pulposus cells and extracellular matrix, forming a passageway through the annulus fibrosis, and transplanting the harvested nucleus pulposus cells and extracellular matrix into the disc through the passageway. For example, the harvested nucleus pulposus cells and extracellular matrix may be introduced into the disc using a needle and syringe or small cannula.
One or more therapeutic substances may be added to the harvested nucleus pulposus cells and extracellular matrix including culture media, growth factors, differentiation factors, hydrogels, polymers, antibiotics, anti-inflammatory medications, or immunosuppressive medications. Alternatively the step of transplanting the harvested nucleus pulposus cells and extracellular matrix may include percutaneously or laparoscopically injecting the engineered disc tissue into the disc being treated.
The relative vascular isolation of the nucleus pulposis imparts isolation of nucleus pulposis cells from the body's immune system. However, even with the lack of an immune system response, the transplantation risks viral disease transmission, i.e. hepatitis, HIV etc. The risk of disease transmission increases in direct proportion to the number donors who provide disc tissue.
SUMMARY OF THE INVENTION
Broadly, this invention resides in tissue banking to guard against the spread of transmittable diseases. Although the description makes specific reference to human disc cells, the invention may be used as a way to provide disease-free disc tissue derived from animal sources, and is applicable as well to other types of biologic tissues and materials such pancreas cells, cartilage cells, and so forth.
REFERENCES:
patent: 2677369 (1954-05-01), Knowles
patent: 3366975 (1968-02-01), Pangman
patent: 3426364 (1969-02-01), Lumb
patent: 3551560 (1970-12-01), Thiele
patent: 3593342 (1971-07-01), Niebauer
patent: 3648294 (1972-03-01), Shahrestani
patent: 3855638 (1974-12-01), Pilliar
patent: 3867728 (1975-02-01), Stubstad et al.
patent: 3875595 (1975-04-01), Froning
patent: 3883902 (1975-05-01), Lynch
patent: 3918099 (1975-11-01), Fuhr et al.
patent: 4229839 (1980-10-01), Schwemmer
patent: 4309777 (1982-01-01), Patil
patent: 4349921 (1982-09-01), Kuntz
patent: 4353888 (1982-10-01), Sefton
patent: 4663358 (1987-05-01), Hyon et al.
patent: 4673649 (1987-06-01), Boyce et al.
patent: 4707872 (1987-11-01), Hessel
patent: 4714469 (1987-12-01), Kenna
patent: 4759766 (1988-07-01), Buettner-Janz et al.
patent: 4772287 (1988-09-01), Ray et al.
patent: 4801299 (1989-01-01), Brendel et al.
patent: 4863477 (1989-09-01), Monson
patent: 4874389 (1989-10-01), Downey
patent: 4904260 (1990-02-01), Ray et al.
patent: 4911718 (1990-03-01), Lee et al.
patent: 4917704 (1990-04-01), Frey et al.
patent: 4932969 (1990-06-01), Frey et al.
patent: 4946378 (1990-08-01), Hirayama et al.
patent: 5002576 (1991-03-01), Fuhrmann et al.
patent: 5035716 (1991-07-01), Downey
patent: 5047055 (1991-09-01), Bao et al.
patent: 5071437 (1991-12-01), Steffee
patent: 5108438 (1992-04-01), Stone
patent: 5123926 (1992-06-01), Pisharodi
patent: 5131850 (1992-07-01), Brockbank
patent: 5171280 (1992-12-01), Baumgartner
patent: 5171281 (1992-12-01), Parsons et al.
patent: 5192326 (1993-03-01), Bao et al.
patent: 5246458 (1993-09-01), Graham
patent: 5258031 (1993-11-01), Salib et al.
patent: 5258043 (1993-11-01), Stone
patent: 5314477 (1994-05-01), Marnay
patent: 5320644 (1994-06-01), Baumgartner
patent: 5370697 (1994-12-01), Baumgartner
patent: 5375823 (1994-12-01), Navas
patent: 5401269 (1995-03-01), Buttner-Janz et al.
patent: 5425773 (1995-06-01), Boyd et al.
patent: 5458642 (1995-10-01), Beer et al.
patent: 5464439 (1995-11-01), Gendler
patent: 5514180 (1996-05-01), Heggeness et al.
patent: 5534028 (1996-07-01), Bao et al.
patent: 5534030 (1996-07-01), Navarro et al.
patent: 5545229 (1996-08-01), Parsons et al.
patent: 5571083 (1996-11-01), Lemelson
patent: 5782851 (1998-07-01), Rassman
patent: 5882328 (1999-03-01), Levy et al.
patent: 5964096 (1999-10-01), Watson et al.
patent: 6110482 (2000-08-01), Khouri et al.
patent: 6184033 (2001-02-01), Smikodub
patent: 6197586 (2001-03-01), Bhatnagar et al.
patent: 6340369 (2002-01-01), Ferree
patent: 6419702 (2002-07-01), Ferree
patent: 6454804 (2002-09-01), Ferree
patent: 6455311 (2002-09-01), Vacanti
patent: 6489165 (2002-12-01), Bhatnagar et al.
patent: 6541028 (2003-04-01), Kuri-Harcuch et al.
patent: 2001/0006948 (2001-07-01), Kang et al.
patent: 2002/0115208 (2002-08-01), Mitchell et al.
patent: 2003/0125782 (2003-07-01), Streeter
Choi, W Sung et al., Distinct Responses of Annulus Fibrosis and Nucleus Pulposus Cells to Growth Factors, 47th Annual Meeting, Orthopaedic Research Society, Feb. 25-28, 2001, San Francisco, California..*
Lumbar Intervertebral Disc Transfer a Canine Study, Steven Frick MD, SPINE vol. 19 No. 16 pp. 1826-1835, 1994.
Orthopedics Today, Jul. 2000.
“Proceedings 14th Annual Meeting” North American Spine Society, Oct. 1999.
“Proceedings 13th annual Meeting” North American Spine Society, Oct. 1998.
North American Spine Society 13 Annual Meeting San Francisco Hilton and towers Oct. 28-31, 1998; Baron Lonner Md et al. Tissue Enineered Regeneration of the Intervertebral Disc.
Gifford Krass Groh Sprinkle Anderson & Citkowski PC
Jackson Suzette J.
LandOfFree
Method of providing cells and other biologic materials for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of providing cells and other biologic materials for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of providing cells and other biologic materials for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3269419